IP Verse

Octapharma Ag opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Octapharma Ag

Patent Number:
EP3226895
Title:
Pharmaceutical Product With Increased Stability Comprising Immunoglobulins
Applicant:
CSL BEHRING AG
Opposition Date:
Apr 22, 2021
Patent Number:
EP2538975
Title:
Immunoglobulin Preparation And Storage System For An Immunoglobulin Preparation
Applicant:
CSL BEHRING AG
Opposition Date:
Jun 18, 2020
Patent Number:
EP3116534
Title:
Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders
Applicant:
BAXALTA GMBH
Opposition Date:
Feb 28, 2020
Patent Number:
EP2345425
Title:
Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs
Applicant:
LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Opposition Date:
Apr 11, 2019
Patent Number:
EP2968434
Title:
C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor Deficency
Applicant:
SHIRE VIROPHARMA INCORPORATED
Opposition Date:
Mar 28, 2018

Latest patents of Octapharma Ag opposed by its competitors

Patent:
EP2707387
Grant Date:
Dec 25, 2019
Title:
A Method Of Increasing The Productivity Of Eucaryotic Cells In The Production Of Recombinant Fviii
Oppositions:
1
Patent:
EP2640413
Grant Date:
Jun 12, 2019
Title:
A Process For Reduction And/Or Removal Of Fxi And Fxia From Solutions Containing Said Coagulation Factors
Oppositions:
1
Patent:
EP2670429
Grant Date:
Apr 4, 2018
Title:
Method For Inactivation/Removal Of Coagulation Factors By Precipitation
Oppositions:
2
Patent:
EP2825555
Grant Date:
Jul 12, 2017
Title:
Improved Process For Production Of Fibrinogen And Fibrinogen Produced Thereby
Oppositions:
2

Competitors of Octapharma Ag

STRAWMAN LIMITED

BIOTEST AG

CSL BEHRING AG

Want to track Octapharma Ag?

Feel free to send us a message here and we will get back to you